Polydex Pharmaceuticals Ltd (OTC Pink - Limited Information:POLXF)

1.13
Delayed Data
As of Aug 16
 0.00 / 0.00%
Today’s Change
0.75
Today|||52-Week Range
1.29
+39.51%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$3.9M

Company Description

Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.

Contact Information

Polydex Pharmaceuticals Ltd.
421 Comstock Road
Toronto Ontario M1L 2H5
P:(416) 755-2231
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

George G. UsherChairman, President & Chief Executive Officer
Sharon L. WardlawChief Operating Officer, Secretary & Treasurer
David JamesteeChief Financial Officer
Linda HughesHead-Media & Public Relations